651 related articles for article (PubMed ID: 18567516)
21. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
22. Comparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of age.
Likar R; Vadlau EM; Breschan C; Kager I; Korak-Leiter M; Ziervogel G
Clin J Pain; 2008; 24(6):536-43. PubMed ID: 18574363
[TBL] [Abstract][Full Text] [Related]
23. Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain.
Davis MP
J Support Oncol; 2012; 10(6):209-19. PubMed ID: 22809652
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study.
Steiner DJ; Sitar S; Wen W; Sawyerr G; Munera C; Ripa SR; Landau C
J Pain Symptom Manage; 2011 Dec; 42(6):903-17. PubMed ID: 21945130
[TBL] [Abstract][Full Text] [Related]
25. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
Mitra F; Chowdhury S; Shelley M; Williams G
Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
[TBL] [Abstract][Full Text] [Related]
26. Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
Skurtveit S; Furu K; Kaasa S; Borchgrevink PC
Eur J Pain; 2009 Oct; 13(9):949-53. PubMed ID: 19095476
[TBL] [Abstract][Full Text] [Related]
27. Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine.
Mercadante S; Porzio G; Fulfaro F; Aielli F; Verna L; Ficorella C; Casuccio A; Riina S; Intravaia G; Mangione S
J Pain Symptom Manage; 2007 Nov; 34(5):532-8. PubMed ID: 17629666
[TBL] [Abstract][Full Text] [Related]
28. Buprenorphine and the transdermal system: the ideal match in pain management.
Budd K
Int J Clin Pract Suppl; 2003 Feb; (133):9-14; discussion 23-4. PubMed ID: 12665118
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain.
Poulain P; Denier W; Douma J; Hoerauf K; Samija M; Sopata M; Wolfram G
J Pain Symptom Manage; 2008 Aug; 36(2):117-25. PubMed ID: 18411010
[TBL] [Abstract][Full Text] [Related]
30. Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.
Freye E; Anderson-Hillemacher A; Ritzdorf I; Levy JV
Pain Pract; 2007 Jun; 7(2):123-9. PubMed ID: 17559481
[TBL] [Abstract][Full Text] [Related]
31. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
Sittl R; Nuijten M; Nautrup BP
Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
[TBL] [Abstract][Full Text] [Related]
32. Buprenorphine TDS: the clinical development rationale and results.
Radbruch L; Vielvoye-Kerkmeer A
Int J Clin Pract Suppl; 2003 Feb; (133):15-8; discussion 23-4. PubMed ID: 12665119
[TBL] [Abstract][Full Text] [Related]
33. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
34. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
35. [Buprenorphine transdermal patch (Norspan tape)].
Hamaguchi S; Ikeda T
Masui; 2013 Jul; 62(7):799-807. PubMed ID: 23905402
[TBL] [Abstract][Full Text] [Related]
36. Buprenorphine TDS: use in daily practice, benefits for patients.
Radbruch L
Int J Clin Pract Suppl; 2003 Feb; (133):19-22; discussion 23-4. PubMed ID: 12665120
[TBL] [Abstract][Full Text] [Related]
37. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
Koltzenburg M; Pokorny R; Gasser UE; Richarz U
Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
[TBL] [Abstract][Full Text] [Related]
38. Transdermal opioids for cancer pain.
Cachia E; Ahmedzai SH
Curr Opin Support Palliat Care; 2011 Mar; 5(1):15-9. PubMed ID: 21325999
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain.
Ruggiero A; Coccia P; Arena R; Maurizi P; Battista A; Ridola V; Attinà G; Riccardi R
Pediatr Blood Cancer; 2013 Mar; 60(3):433-7. PubMed ID: 23034996
[TBL] [Abstract][Full Text] [Related]
40. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]